Financials

News Discussions Technicals Seasonals

688302 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Hinova Pharmaceuticals, Inc. engages in the research and development of pharmaceutical products. It offers castration-resistant prostate cancer treatment and anti-gout and hyperuricemia drugs. The company was founded by Yuan Wei Chen and Xing Hai Li on February 5, 2013 and is headquartered in Chengdu, China.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

688302 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company